Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (161-170 of 297) with videos related to

Pageof 30
Sort By:
The European Respiratory Journal|July 30, 2016
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung functionCarlo Albera, Ulrich Costabel, Elizabeth A Fagan, et al.
American Journal of Respiratory and Critical Care Medicine|August 5, 2015
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm ValidationDaina B Esposito, Stephan Lanes, Macarius Donneyong, et al.
Chest|August 7, 2021
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled TrialRobert P Baughman, Oksana A Shlobin, Rohit Gupta, et al.
Scientific Reports|March 7, 2018
Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4Luis R Rodriguez, Margaret Emblom-Callahan, Mantej Chhina, et al.
Chest|October 19, 2020
Association Between Anticoagulation and Survival in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Patient RegistryChristopher S King, Elizabeth Freiheit, A Whitney Brown, et al.
Respiratory Medicine|August 27, 2020
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosisSteven D Nathan, A Whitney Brown, Nesrin Mogulkoc, et al.
Advances in Therapy|June 30, 2023
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical StudiesJürgen Behr, Steven D Nathan, Ulrich Costabel, et al.
Respiratory Research|January 7, 2021
Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomesJean Pastre, Scott Barnett, Inga Ksovreli, et al.
Respirology (Carlton, Vic.)|January 5, 2011
The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosisSteven D Nathan, Nargues Weir, Oksana A Shlobin, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2010
Supranormal expiratory airflow after bilateral lung transplantation is associated with improved survivalMichael Eberlein, Solbert Permutt, Robert H Brown, et al.
Pageof 30

Showing results (161-170 of 297) with videos related to

Sort By:
Pageof 30
The European Respiratory Journal|July 30, 2016
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung functionCarlo Albera, Ulrich Costabel, Elizabeth A Fagan, et al.
American Journal of Respiratory and Critical Care Medicine|August 5, 2015
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm ValidationDaina B Esposito, Stephan Lanes, Macarius Donneyong, et al.
Chest|August 7, 2021
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled TrialRobert P Baughman, Oksana A Shlobin, Rohit Gupta, et al.
Scientific Reports|March 7, 2018
Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4Luis R Rodriguez, Margaret Emblom-Callahan, Mantej Chhina, et al.
Chest|October 19, 2020
Association Between Anticoagulation and Survival in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Patient RegistryChristopher S King, Elizabeth Freiheit, A Whitney Brown, et al.
Respiratory Medicine|August 27, 2020
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosisSteven D Nathan, A Whitney Brown, Nesrin Mogulkoc, et al.
Advances in Therapy|June 30, 2023
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical StudiesJürgen Behr, Steven D Nathan, Ulrich Costabel, et al.
Respiratory Research|January 7, 2021
Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomesJean Pastre, Scott Barnett, Inga Ksovreli, et al.
Respirology (Carlton, Vic.)|January 5, 2011
The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosisSteven D Nathan, Nargues Weir, Oksana A Shlobin, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2010
Supranormal expiratory airflow after bilateral lung transplantation is associated with improved survivalMichael Eberlein, Solbert Permutt, Robert H Brown, et al.
Pageof 30